 Participants will receive interval compressed every 2 weeks alternating courses of chemotherapy with vincristine, doxorubicin, and cyclophosphamide VDC and with ifosfamide and etoposide IE. Doxorubicin will be omitted following a total cumulative dose of 375 mgm2. Local control measures surgery andor radiation therapy will be instituted after 6 courses of chemotherapy. Total duration of treatment is approximately 29 weeks. 